Patent · US Active

Modulators of TNF-αsignaling

US8518999B2 · kind B2 · utility

2Cited by
39References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 1, 2005
Grant dateAug 27, 2013
Priority date
Expiry dateJun 21, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D403/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compounds which are modulators of TNF-α signaling and methods of use thereof for treating a patient having a TNF-α mediated condition. The compounds can be represented by the following structural formulas:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.